NO160782C - Analogifremgangsmaate for fremstilling av terapeutisk aktiv 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo-(ij)-kinolizin-2-carboxylsyre. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktiv 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo-(ij)-kinolizin-2-carboxylsyre.Info
- Publication number
- NO160782C NO160782C NO834093A NO834093A NO160782C NO 160782 C NO160782 C NO 160782C NO 834093 A NO834093 A NO 834093A NO 834093 A NO834093 A NO 834093A NO 160782 C NO160782 C NO 160782C
- Authority
- NO
- Norway
- Prior art keywords
- benzo
- dihydro
- oxo
- dimethyl
- kinolizin
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 2
- -1 alkylaminoalkyl ester salts Chemical class 0.000 abstract 2
- 150000001263 acyl chlorides Chemical class 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Quinoline Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO883544A NO168101C (no) | 1982-11-12 | 1988-08-10 | 6-fluor-5-methyl-1,2,3,4-tetrahydrokinaldin for anvendelse som utgangsmateriale ved fremstilling av terapeutisk aktive forbindelser |
NO883545A NO883545D0 (no) | 1982-11-12 | 1988-08-10 | Diethyl-2-(n-(6-fluor-5-methyl-1,2,3,4-tetra-hydrokinaldinyl))-methylenmalonat for anvendelse som utgangsmateriale ved fremstilling av terapeutisk aktive forbindelser. |
NO883546A NO168102C (no) | 1982-11-12 | 1988-08-10 | 5-carboxyl-6-fluorkinaldin for anvendelse som utgangsmateriale ved fremstilling av terapeutisk aktive forbindelser |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/441,245 US4472405A (en) | 1982-11-12 | 1982-11-12 | Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
NO834093L NO834093L (no) | 1984-05-14 |
NO160782B NO160782B (no) | 1989-02-20 |
NO160782C true NO160782C (no) | 1989-05-31 |
Family
ID=23752110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO834093A NO160782C (no) | 1982-11-12 | 1983-11-09 | Analogifremgangsmaate for fremstilling av terapeutisk aktiv 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo-(ij)-kinolizin-2-carboxylsyre. |
Country Status (22)
Country | Link |
---|---|
US (1) | US4472405A (pt) |
EP (1) | EP0109284B1 (pt) |
JP (1) | JPH0826017B2 (pt) |
KR (1) | KR890000864B1 (pt) |
AT (1) | ATE39926T1 (pt) |
AU (1) | AU568319B2 (pt) |
CA (2) | CA1254568A (pt) |
CS (1) | CS390391A3 (pt) |
DE (1) | DE3378912D1 (pt) |
EG (1) | EG16492A (pt) |
ES (1) | ES527163A0 (pt) |
FI (1) | FI73213C (pt) |
GR (1) | GR79402B (pt) |
IE (1) | IE56232B1 (pt) |
IL (1) | IL70198A (pt) |
IN (1) | IN161391B (pt) |
MX (1) | MX7314E (pt) |
NO (1) | NO160782C (pt) |
NZ (1) | NZ206233A (pt) |
OA (1) | OA07586A (pt) |
PT (1) | PT77649B (pt) |
ZA (1) | ZA838436B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3519926A1 (de) * | 1985-06-04 | 1986-12-04 | Bayer Ag | Indolinderivate, verfahren zu ihrer herstellung und diese indolinderivate enthaltende kosmetische lichtschutzmittel |
US4898945A (en) * | 1986-01-22 | 1990-02-06 | Minnesota Mining And Manufacturing Company | Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid |
CA1302413C (en) * | 1986-01-22 | 1992-06-02 | Bruce E. Williams | Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo- 1h,5h-benzo[ij]quinolizine-2-carboxylic acid |
GB9827865D0 (en) * | 1998-12-18 | 1999-02-10 | Woodcock Fiona | Medicament |
DE10312346A1 (de) * | 2003-03-20 | 2004-09-30 | Bayer Healthcare Ag | Kontrolliertes Freisetzungssystem |
DE10351448A1 (de) | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
DE102005055385A1 (de) * | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
DE102006010642A1 (de) * | 2006-03-08 | 2007-09-27 | Bayer Healthcare Aktiengesellschaft | Arzneimittelformulierungen, enthaltend Fluorchinolone |
DE102006010643A1 (de) | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
DE102007026550A1 (de) | 2007-06-08 | 2008-12-11 | Bayer Healthcare Ag | Extrudate mit verbesserter Geschmacksmaskierung |
DE102007055341A1 (de) | 2007-11-19 | 2009-05-20 | Bayer Animal Health Gmbh | Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren |
WO2012049156A1 (en) | 2010-10-12 | 2012-04-19 | Bayer Animal Health Gmbh | Non-starch based soft chewables |
CN105025885B (zh) | 2012-12-19 | 2022-04-08 | 拜耳动物保健有限责任公司 | 具有改善的接受性和良好贮存稳定性的片剂 |
MD4291C1 (ro) * | 2013-12-27 | 2015-02-28 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Preparat medicamentos pentru tratamentul otitelor |
EP4025220A4 (en) * | 2019-09-06 | 2023-10-04 | Elanco US Inc. | TASTY VETERINARY MEDICINAL COMPOSITIONS IN GRANULE FORM |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE793524A (fr) * | 1971-12-30 | 1973-06-29 | Riker Laboratories Inc | Acides benzoquinolizine-carboxyliques et leurs derives |
ZA728444B (en) * | 1971-12-30 | 1973-10-31 | Riker Laboratories Inc | Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof |
JPS5630964A (en) * | 1979-08-22 | 1981-03-28 | Kyorin Pharmaceut Co Ltd | Novel substituted quinolinecarboxylic acid and its preparation |
JPS5655388A (en) | 1979-10-11 | 1981-05-15 | Otsuka Pharmaceut Co Ltd | Benzo ij quinolidine-2-carboxylic acid derivative, and its preparation |
US4301289A (en) * | 1980-02-19 | 1981-11-17 | Minnesota Mining And Manufacturing Company | Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid |
JPS59155381A (ja) * | 1983-02-22 | 1984-09-04 | Kyorin Pharmaceut Co Ltd | ベンゾキノリジンカルボン酸誘導体及びその製造法 |
-
1982
- 1982-11-12 US US06/441,245 patent/US4472405A/en not_active Expired - Lifetime
-
1983
- 1983-10-27 CA CA000439826A patent/CA1254568A/en not_active Expired
- 1983-11-09 NO NO834093A patent/NO160782C/no unknown
- 1983-11-10 OA OA58156A patent/OA07586A/xx unknown
- 1983-11-10 ES ES527163A patent/ES527163A0/es active Granted
- 1983-11-11 ZA ZA838436A patent/ZA838436B/xx unknown
- 1983-11-11 NZ NZ206233A patent/NZ206233A/en unknown
- 1983-11-11 IN IN1382/CAL/83A patent/IN161391B/en unknown
- 1983-11-11 JP JP58212306A patent/JPH0826017B2/ja not_active Expired - Lifetime
- 1983-11-11 MX MX8310883U patent/MX7314E/es unknown
- 1983-11-11 DE DE8383306908T patent/DE3378912D1/de not_active Expired
- 1983-11-11 IE IE2639/83A patent/IE56232B1/en not_active IP Right Cessation
- 1983-11-11 PT PT77649A patent/PT77649B/pt not_active IP Right Cessation
- 1983-11-11 AU AU21181/83A patent/AU568319B2/en not_active Ceased
- 1983-11-11 AT AT83306908T patent/ATE39926T1/de not_active IP Right Cessation
- 1983-11-11 GR GR72947A patent/GR79402B/el unknown
- 1983-11-11 FI FI834147A patent/FI73213C/fi not_active IP Right Cessation
- 1983-11-11 IL IL70198A patent/IL70198A/xx not_active IP Right Cessation
- 1983-11-11 EP EP83306908A patent/EP0109284B1/en not_active Expired
- 1983-11-12 KR KR1019830005376A patent/KR890000864B1/ko not_active IP Right Cessation
- 1983-11-12 EG EG70383A patent/EG16492A/xx active
-
1988
- 1988-08-05 CA CA000574069A patent/CA1280755C/en not_active Expired - Fee Related
-
1991
- 1991-12-19 CS CS913903A patent/CS390391A3/cs unknown
Also Published As
Publication number | Publication date |
---|---|
JPH0826017B2 (ja) | 1996-03-13 |
IE832639L (en) | 1984-05-12 |
ES8504727A1 (es) | 1985-05-01 |
EG16492A (en) | 1994-11-30 |
GR79402B (pt) | 1984-10-22 |
OA07586A (fr) | 1985-03-31 |
NO160782B (no) | 1989-02-20 |
NO834093L (no) | 1984-05-14 |
DE3378912D1 (de) | 1989-02-16 |
PT77649A (en) | 1983-12-01 |
IE56232B1 (en) | 1991-05-22 |
KR840006659A (ko) | 1984-12-01 |
CS390391A3 (en) | 1992-09-16 |
NZ206233A (en) | 1986-10-08 |
PT77649B (en) | 1986-03-19 |
ZA838436B (en) | 1985-06-26 |
FI834147A0 (fi) | 1983-11-11 |
CA1254568A (en) | 1989-05-23 |
EP0109284A1 (en) | 1984-05-23 |
JPS59112969A (ja) | 1984-06-29 |
ES527163A0 (es) | 1985-05-01 |
ATE39926T1 (de) | 1989-01-15 |
IN161391B (pt) | 1987-11-28 |
FI73213B (fi) | 1987-05-29 |
EP0109284B1 (en) | 1989-01-11 |
MX7314E (es) | 1988-05-11 |
IL70198A (en) | 1988-11-15 |
KR890000864B1 (ko) | 1989-04-11 |
IL70198A0 (en) | 1984-02-29 |
CA1280755C (en) | 1991-02-26 |
AU2118183A (en) | 1984-05-17 |
US4472405A (en) | 1984-09-18 |
AU568319B2 (en) | 1987-12-24 |
FI834147A (fi) | 1984-05-13 |
FI73213C (fi) | 1987-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO160782C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktiv 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo-(ij)-kinolizin-2-carboxylsyre. | |
NO171209C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive morfinanestere | |
NO173238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser | |
NO784397L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater | |
NO173547C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater | |
NO171214C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater | |
NO802087L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater | |
IE38302B1 (en) | Aromatic hydroxy amines | |
NO301372B1 (no) | Fremgangsmåte for fremstilling av et farmasöytisk tålbart salt av klavulansyre | |
ES8702405A1 (es) | Procedimiento para la obtencion de acidos benzo(ij) quinolizina-2-carboxilicos y sus derivados | |
NO157330C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive 3-metylflavon-8-karboksylsyreestere. | |
IT7850230A0 (it) | Derivati di alfa-alogenometilammino acidi ad attivita' farmaceutica eprocedimento per la loro preparazione | |
IT8024165A0 (it) | Esteri di acidi dialogenovinilciclopropancarbossili ci, procedimento per la loro preparazione e loro impiego per combattere organismi nocivi e anche alcooli alfa-alogenoetinil-3-fenossi-benzilici. | |
IT1101667B (it) | Esteri 3-fenossi-alfa-vinil-benzilici di acidi vinil-ciclopropan-carbossilici, procedimento per la loro preparatione e loro impiego per combattere organismi nocivi | |
NO163133C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktiv 5r, 6s, 8r-6-(1-hydroxyethyl)-2-(2-carbamoyloxy-ethylthio)-penem-3-carboxylsyre. | |
NO167982C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater. | |
SE8301687D0 (sv) | 8-cyano-6,7-dihydro-5-metyl-1-oxo-1h-,5h-benso(ij)kinolizin-2-karboxylsyror och forfarande for framstellning derav | |
DK550183A (da) | 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo/ij/-quinolizin-2-carboxylsyre, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved udoevelse af fremgangsmaaden | |
DE3461464D1 (en) | Derivatives of d-2-(6-methoxy-2-naphthyl)-propionic acid having therapeutical activity, process for their preparation and pharmaceutical compositions containing them | |
JPS52148042A (en) | New derivative of 33*3*55dichlorophenyl**ureido acetic acid and process for manufacture thereof and germicide containing said derivative as active ingredient | |
NO850154L (no) | Fremgangsmaate ved fremstilling av nye terapeutisk aktive karboksylsyrederivater | |
IT8048019A0 (it) | Procedimento per la preparazione di esteri di acidi carbossilici dotati di attivita' pesticida | |
NO165396C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridin-5-karboksylsyre-estere. | |
GB2011887A (en) | Antiallergic agent | |
IT8048484A0 (it) | Derivati di alfa-alogenometilammino acidi ad attivita' farmaceutica eprocedimento per la loro preparazione |